Health Services: The Evolution of Regulation, Competition, and Innovation
Now more than ever before, not only medical but also economic and social issues influence how health care is organized, governed, financed, and delivered.
Our empirical research advances understanding of the economics and regulation of the health services industry, with an emphasis on the biopharmaceutical and medical device industries. Faculty researchers examine a variety of issues, most typically around firm, industry, and regulatory organization and performance. Past and ongoing research includes the speed of drug development, sales and promotion strategies during adverse regulatory events, regulatory compliance, and the effect of eHealth on health behaviors and outcomes. Some research projects entail the development and analysis of proprietary data, while others are conducted in collaboration with the U.S. Food and Drug Administration (FDA) and Centers for Disease Control (CDC).
Principal Investigator and Convener: Jeffrey Macher
Does the Internet Improve Health Behaviors and Health Outcomes? Evidence from the National Health Interview Survey March, 2016Technological Development at the Boundaries of the Firm: A Knowledge -Based Examination in Drug Development August, 2012